In recent trading, shares of Gilead Sciences Inc (Symbol: GILD) have crossed above the average analyst 12-month target price of $111.77, changing hands for $112.26/share. When a stock reaches the ...

Fan Zhang, PhD, sees artificial intelligence as ... Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Optum, Pfizer, and ReCor. MBB is a founder of Mestag Therapeutics and a consultant ...

Gilead said two ex­per­i­men­tal once-a-year ver­sions of its HIV pre­ven­tion shot lenaca­pavir passed muster in an ear­ly-stage study with a small group of healthy par­tic­i­pants … ...

Acclaimed Chinese-American mathematician Huaxin Lin has returned to China for a full-time research position in Shanghai after nearly four decades in the United States. The 69-year-old joined the ...

After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the drug has shown promise being dosed even further apart at only once a year.

Across the recent three months, 14 analysts have shared their insights on Gilead Sciences GILD, expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates ...

Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months.

Once-Daily Orals and In-Depth Look at Adolescent Pharmacokinetic, Safety and Efficacy Data – FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first data ...

Gilead Sciences (GILD) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the ...

Investors are keen on ByteDance's AI potential. ByteDance cofounder Zhang Yiming has become China’s richest man as investors bet on companies with AI potential. Zhang’s fortune has grown to $ ...

The research program led by Dr. Haichong (Kai) Zhang focuses on the interface of medical robotics, sensing, and imaging, and to develop a novel biomedical imaging systems that delineates both ...

IF an unconventional path to the NBA is the topic, Jeremy Lin sure is one to talk. And that's why the New Taipei Kings star believes it’s still sky’s the limit for Kai Sotto when it comes to ...